Glycogen Branching Enzyme Deficiency in Horses: GBED in Foals

Vet Teletriage

Worried this is an emergency? Talk to a vet now.

Sidekick.Vet connects you with licensed veterinary professionals for urgent teletriage — get fast guidance on whether your pet needs emergency care. Just $35, no subscription.

Get Help at Sidekick.Vet →
Quick Answer
  • See your vet immediately if a newborn foal is weak, cold, collapses, has seizures, or struggles to breathe.
  • GBED is a fatal inherited disease caused by a mutation in the GBE1 gene. Affected foals cannot store glycogen normally in muscle, heart, liver, and brain.
  • It is most recognized in Quarter Horses and related breeds, including Paint Horses. Carrier horses can look completely normal.
  • There is no curative treatment. Care focuses on confirming the diagnosis, supporting the foal, and making humane quality-of-life decisions with your vet.
  • Prevention depends on genetic testing before breeding. A carrier-to-carrier mating has a 25% chance of producing an affected foal.
Estimated cost: $300–$6,000

What Is Glycogen Branching Enzyme Deficiency in Horses?

Glycogen branching enzyme deficiency, or GBED, is a severe inherited disease seen in Quarter Horse lines and related breeds. It affects how a foal stores glycogen, the body's backup form of sugar. Without normal glycogen branching enzyme activity, tissues cannot build or use energy stores correctly, especially in the heart, skeletal muscle, liver, and brain.

GBED is inherited in an autosomal recessive pattern. That means a foal must receive one mutated gene copy from each parent to be affected. Carrier mares and stallions usually look healthy, so the condition can stay hidden in a breeding program unless genetic testing is done.

Some affected pregnancies end in late-term abortion or stillbirth. Foals that are born alive are often weak from the start and may develop low body temperature, low blood sugar, muscle weakness, collapse, or breathing problems. The prognosis is grave, and published veterinary references report that affected foals die or are euthanized, often within the first days to months of life.

Symptoms of Glycogen Branching Enzyme Deficiency in Horses

  • Weakness at birth or within the first day
  • Low body temperature
  • Decreased muscle tone or generalized muscle weakness
  • Flexural limb deformities or abnormal stance
  • Recurrent low blood sugar, collapse, or faint episodes
  • Rapid breathing, respiratory failure, or poor stamina
  • Seizures or sudden death
  • Late-term abortion or stillbirth

See your vet immediately if a foal is weak, cold, not nursing, breathing hard, collapsing, or showing seizure-like activity. These signs are not specific to GBED and can overlap with sepsis, pneumonia, prematurity, and other life-threatening newborn problems. Fast veterinary evaluation matters because some of those conditions are treatable, even though GBED itself is not curable.

What Causes Glycogen Branching Enzyme Deficiency in Horses?

GBED is caused by an inherited mutation in the GBE1 gene, which codes for the glycogen branching enzyme. This enzyme is needed to make normal branched glycogen. When the enzyme is missing or severely reduced, the body cannot store energy in the usual way, and abnormal glycogen-like material can build up in tissues.

Because the disease is autosomal recessive, both the mare and stallion must pass on the mutation for a foal to be affected. If both parents are carriers, each pregnancy has a 25% chance of an affected foal, a 50% chance of a carrier foal, and a 25% chance of a foal with no copies of the mutation.

GBED is especially important in Quarter Horses and related breeds, including Paint Horses. UC Davis reports carrier frequencies around 8.3% in Quarter Horses and 7.1% in Paint Horses, which is why pre-breeding genetic screening is such an important prevention tool.

How Is Glycogen Branching Enzyme Deficiency in Horses Diagnosed?

Your vet will usually start with a full newborn foal exam and basic testing to rule out more common emergencies. Bloodwork may show low white blood cell counts, low blood glucose, and increased muscle and liver-associated enzymes such as CK, AST, and GGT. These changes can support suspicion, but they do not prove GBED on their own.

A definitive diagnosis requires genetic testing for the GBED mutation. Testing can be performed on hair roots, blood, or tissue samples. In some cases, especially after abortion, stillbirth, or death of a foal, your vet may also recommend tissue submission or necropsy to help confirm the diagnosis and rule out infectious causes.

Muscle biopsy or special tissue staining may show abnormal glycogen patterns, including reduced normal PAS staining and abnormal inclusions. Still, current veterinary references emphasize that DNA testing is the clearest way to confirm GBED. If a foal is diagnosed, your vet may also recommend testing the mare and stallion so future breeding decisions can be planned more safely.

Treatment Options for Glycogen Branching Enzyme Deficiency in Horses

Spectrum of Care means you have options. Here are treatment tiers at different price points.

Budget-Conscious Care

$300–$1,200
Best for: Foals with severe weakness or poor prognosis when the pet parent needs clear answers and compassionate decision-making without prolonged hospitalization.
  • Urgent farm call or clinic exam
  • Temperature, glucose, and hydration assessment
  • Basic bloodwork if available
  • Discussion of likely prognosis and quality of life
  • Targeted genetic testing submission
  • Humane euthanasia planning if the foal is suffering or rapidly declining
Expected outcome: Poor to grave. There is no curative treatment for GBED, and survival is not expected.
Consider: This approach can confirm or strongly support the diagnosis while limiting costs, but it offers less intensive monitoring and fewer short-term supportive measures.
Most Common

Recommended Standard Treatment

$1,200–$3,500
Best for: Foals where the diagnosis is still being sorted out and your vet is also treating other possible newborn emergencies such as sepsis, pneumonia, or prematurity.
  • Emergency foal exam and stabilization
  • CBC, chemistry, glucose monitoring, and muscle enzyme testing
  • IV fluids or dextrose support as directed by your vet
  • Oxygen or nursing support if needed
  • Genetic testing for the foal and breeding stock
  • Referral discussion and quality-of-life reassessment
  • Euthanasia and body care planning if the foal declines
Expected outcome: Poor to grave if GBED is confirmed. Supportive care may briefly stabilize some foals but does not change the fatal nature of the disease.
Consider: This tier gives a more complete workup and short-term support, but costs rise quickly and treatment may still end in euthanasia once GBED is confirmed.

Advanced / Critical Care

$3,500–$6,000
Best for: Critically ill foals in referral settings, especially when your vet needs to distinguish GBED from other potentially treatable neonatal diseases.
  • Referral hospital or neonatal ICU care
  • Continuous monitoring and repeated blood glucose and chemistry checks
  • Advanced respiratory and cardiovascular support
  • Expanded infectious disease testing and imaging to rule out other causes
  • Necropsy or specialized tissue testing if the foal dies
  • Breeding-program genetic counseling and broader herd testing
Expected outcome: Grave. Even with intensive care, GBED has no successful curative treatment reported in standard veterinary references.
Consider: Advanced care can provide the most diagnostic clarity and short-term support, but it is resource-intensive and usually does not change the final outcome if GBED is present.

Cost estimates as of 2026-03. Actual costs vary by location, clinic, and individual case.

Questions to Ask Your Vet About Glycogen Branching Enzyme Deficiency in Horses

Bring these questions to your vet appointment to get the most out of your visit.

  1. What problems are most urgent in my foal right now, and which ones could still be treatable?
  2. Do my foal's signs fit GBED, or are you more concerned about sepsis, pneumonia, prematurity, or another condition?
  3. What tests do you recommend today, and which ones are needed to confirm GBED?
  4. Can we send genetic testing on the foal, mare, and stallion, and how long will results take?
  5. What short-term supportive care is reasonable for my foal, and what outcome should I realistically expect?
  6. How will we judge quality of life if my foal cannot stand, nurse, or breathe normally?
  7. If euthanasia becomes the kindest option, what aftercare choices are available in my area and what cost range should I expect?
  8. How should we change future breeding plans to avoid another affected foal?

How to Prevent Glycogen Branching Enzyme Deficiency in Horses

GBED is prevented through genetic screening before breeding, not through vaccines, supplements, or foal management after birth. Because carriers usually look normal, testing is the only reliable way to know whether a mare or stallion carries the mutation.

The key goal is to avoid carrier-to-carrier matings. If two carriers are bred, each foal has a 25% risk of being affected. Breeding a carrier to a horse that tests clear will not produce an affected foal, though some offspring may still be carriers. Your vet can help you interpret results in the context of your breeding goals.

In Quarter Horse breeding programs, GBED testing is widely used and is included in common genetic screening panels. UC Davis notes that the AQHA requires GBED testing for breeding stallions. If you have had a late-term abortion, stillbirth, or weak foal in a related bloodline, ask your vet whether GBED testing should be part of your next breeding plan.

Find a Vet Near You